HAT-1

N/A

Report date: 2023/04/02 21:28:36

Base Information

Drug NameHAT-1
Drug Alias NameHAT-1
ClassificationOther
Mechanisms of ActionHistone deacetylase 1 inhibitors
TargetsHistone deacetylase 1
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEpizyme Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpizyme Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A